Induction Chemotherapy Followed by IMRT or Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

NCT05527470 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

440

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

DRUG: Gemcitabine,Cisplatin
RADIATION: Intensity-modulated radiation therapy (IMRT)
DRUG: Cisplatin

Sponsor

Wei Jiang

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]